Medicosnext
Basel, 13 March 2020 – Roche, a global pioneer in pharmaceuticals and diagnostics, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in …
Read More »Roche’s cobas SARS-CoV-2 test receives FDA Emergency Use Authorization
